FDA Advisory Committee Recommmends FDA Approval of Herceptin for Treatment of Breast CancerAmerican Cancer Society The Food and Drug Administration's (FDA) Oncology Drugs Advisory Committee has recommended (September 3, 1998) that the FDA approve the drug Herceptin, a biologically engineered antibody that has shown promise in treating women with advanced breast cancer. The FDA is not bound by the committee's recommendations, but usually follows them. A final decision is expected in November. More information on the current availability of Herceptin can be obtained by calling the manufacturer, Genentech, at 888-777-4464.
For more information, or to contact American Cancer Society, see their website at: www.cancer.org |
 |
Email Article To A Friend |  |
Link to us! |
